New JerseyImproves access to lower cost generic and biosimilar drugs and revises certain requirements regarding dispensing of biosimilar drugs by pharmacies.*
What it does
Plain-language analysis is being updated.
Use the official record and source text while enrichment finishes.
Where do you stand?
Choose your position
Tell your reps
Take a position to see your representatives and ways to contact them.
Where it stands
- Introduced
- Passed 1st Chamber
- Passed 2nd Chamber
- To Governor
- Became Law
Looking ahead
No hearings or votes scheduled.
History
- 2026
- Jun 4Reported out of Assembly Comm. with Amendments, 2nd ReadingLatest
- Vote recorded Reported out of Assembly committee with amendments. Result: pass.Lower
- Jan 13Introduced, Referred to Assembly Financial Institutions and Insurance CommitteeIntroduced
- Jun 4Reported out of Assembly Comm. with Amendments, 2nd ReadingLatest